Respiratory tract infections and pneumonia

Periodontology 2000

Volumn 49, Issue 1, 2009, Pages 151-165

  McChlery, Susan ^a   Ramage, Gordon ^a   Bagg, Jeremy ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRONCHITIS; COMMON COLD; HAEMOPHILUS INFLUENZAE; HUMAN; INFLUENZA; INFLUENZA VIRUS A H5N1; LEGIONELLA PNEUMOPHILA; MICROBIOLOGY; MYCOSIS; PATHOGENICITY; PATHOLOGY; PNEUMONIA; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT MUCOSA; STREPTOCOCCUS; TUBERCULOSIS; VIROLOGY;

BRONCHITIS; COMMON COLD; HAEMOPHILUS INFLUENZAE; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; LEGIONELLA PNEUMOPHILA; MYCOSES; PNEUMONIA; RESPIRATORY MUCOSA; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS; TUBERCULOSIS;

EID: 57849119733     PISSN: 09066713     EISSN: 16000757     Source Type: Journal    
DOI: 10.1111/j.1600-0757.2008.00278.x     Document Type: Article

References (115)

1. Adamou JE, Wizemann TM, Barren P, Langermann S. Adherence of Streptococcus pneumoniae to human bronchial epithelial cells (BEAS-2B). Infect Immun 1998 : 66 : 820 822.
2. Atlas RM, Williams JF, Huntington MK. Legionella contamination of dental-unit waters. Appl Environ Microbiol 1995 : 61 : 1208 1213.
3. Austrian R. Pneumococcus: the first one hundred years. Rev Infect Dis 1981 : 3 : 183 189.
4. Azarpazhooh A, Leake JL. Systematic review of the association between respiratory diseases and oral health. J Periodontol 2006 : 77 : 1465 1482.
5. Barnes PD, Marr KA. Aspergillosis: spectrum of disease, diagnosis, and treatment. Infect Dis Clin North Am 2006 : 20 : 545 561, vi.
6. Bartlett JG, Dowell SF, Mandell LA, File TM Jr., Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000 : 31 : 347 382.
7. Benin AL, Benson RF, Besser RE. Trends in legionnaires disease, 1980-1998: declining mortality and new patterns of diagnosis. Clin Infect Dis 2002 : 35 : 1039 1046.
8. Benson RF, Fields BS. Classification of the genus Legionella. Semin Respir Infect 1998 : 13 : 90 99.
9. Bentham RH, Broadbent CR. A model for autumn outbreaks of Legionnaires' disease associated with cooling towers, linked to system operation and size. Epidemiol Infect 1993 : 111 : 287 295.
10. Bergstrom CT, McElhany P, Real LA. Transmission bottlenecks as determinants of virulence in rapidly evolving pathogens. Proc Natl Acad Sci USA 1999 : 96 : 5095 5100.
11. Boshuizen HC, Neppelenbroek SE, van Vliet H, Schellekens JF, den Boer JW, Peeters MF, Conyn-van Spaendonck MA. Subclinical Legionella infection in workers near the source of a large outbreak of Legionnaires disease. J Infect Dis 2001 : 184 : 515 518.
12. Brankston G, Gitterman L, Hirji Z, Lemieux C, Gardam M. Transmission of influenza A in human beings. Lancet Infect Dis 2007 : 7 : 257 265.
13. Brunham RC, Plummer FA, Stephens RS. Bacterial antigenic variation, host immune response, and pathogen-host coevolution. Infect Immun 1993 : 61 : 2273 2276.
14. Buzina W, Lass-Florl C, Kropshofer G, Freund MC, Marth E. The polypore mushroom Irpex lacteus, a new causative agent of fungal infections. J Clin Microbiol 2005 : 43 : 2009 2011.
15. CDC. Haemophilus influenzae Serotype b (Hib) disease. National Centre for Immunisation and Respiratory Disease: Division of Bacterial Diseases. http://www.cdc.gov/ncidod/dbmd/diseaseinfo/haeminfluserob-t.htm [accessed 4 April 2008].
16. Chakravorty S, Sen MK, Tyagi JS. Diagnosis of extrapulmonary tuberculosis by smear, culture, and PCR using universal sample processing technology. J Clin Microbiol 2005 : 43 : 4357 4362.
17. Chan PK. Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis 2002 : 34 (Suppl 2 S58 S64.
18. Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect Dis Clin North Am 2006 : 20 : 507 544, v-vi.
19. Cianciotto NP, Bangsborg JM, Eisenstein BI, Engleberg NC. Identification of mip-like genes in the genus Legionella. Infect Immun 1990 : 58 : 2912 2918.
20. Cinatl J Jr., Michaelis M, Doerr HW. The threat of avian influenza A (H5N1). Part IV: development of vaccines. Med Microbiol Immunol 2007 : 196 : 213 225.
21. Cinatl J Jr., Michaelis M, Doerr HW. The threat of avian influenza A (H5N1). Part III: antiviral therapy. Med Microbiol Immunol 2007 : 196 : 203 212.
22. Cinatl J Jr., Michaelis M, Doerr HW. The threat of avian influenza A (H5N1). Part I: epidemiologic concerns and virulence determinants. Med Microbiol Immunol 2007 : 196 : 181 190.
23. Clarke SC, Reid JA, Thom L, Diggle MA, McChlery S, Scott K, Edwards GF. Erythromycin resistance among invasive pneumococci in Scotland, 1994-2003. Br J Biomed Sci 2005 : 62 : 28 30.
24. Clarke SC, Scott KJ, McChlery SM. Erythromycin resistance in invasive serotype 14 pneumococci is highly related to clonal type. J Med Microbiol 2004 : 53 : 1101 1103.
25. Cockeran R, Anderson R, Feldman C. The role of pneumolysin in the pathogenesis of Streptococcus pneumoniae infection. Curr Opin Infect Dis 2002 : 15 : 235 239.
26. Conces DJ Jr. Endemic fungal pneumonia in immunocompromised patients. J Thorac Imaging 1999 : 14 : 1 8.
27. Conti B, Tabarean I, Andrei C, Bartfai T. Cytokines and fever. Front Biosci 2004 : 9 : 1433 1449.
28. Corn PG, Anders J, Takala AK, Kayhty H, Hoiseth SK. Genes involved in Haemophilus influenzae type b capsule expression are frequently amplified. J Infect Dis 1993 : 167 : 356 364.
29. Cornely OA, Vehreschild JJ, Ullmann AJ. Is there a role for polyenes in treating invasive mycoses? Curr Opin Infect Dis 2006 : 19 : 565 570.
30. Cundell DR, Gerard NP, Gerard C, Idanpaan-Heikkila I, Tuomanen EI. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 1995 : 377 : 435 438.
31. Dixon DM, McNeil MM, Cohen ML, Gellin BG, La Montagne JR. Fungal infections: a growing threat. Public Health Rep 1996 : 111 : 226 235.
32. Dockrell DH. Salvage therapy for invasive aspergillosis. J Antimicrob Chemother 2008 : 61 (Suppl 1 i41 i44.
33. Domej W, Hermann J, Krause R, Wehrschutz M, Maier A, Flogel E. Lung cavities, mycetomas and hemoptysis. Wien Med Wochenschr 2007 : 157 : 466 472.
34. Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 2005 : 5 : 718 725.
35. Edelstein PH. The laboratory diagnosis of Legionnaires' disease. Semin Respir Infect 1987 : 2 : 235 241.
36. Edelstein PH. Antimicrobial chemotherapy for Legionnaires disease: time for a change. Ann Intern Med 1998 : 129 : 328 330.
37. CDC. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006 : 55 : 301 305.
38. Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Kayhty H, Karma P, Kohberger R, Siber G, Makela PH. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001 : 344 : 403 409.
39. Feng Y, Gao GF. Towards our understanding of SARS-CoV, an emerging and devastating but quickly conquered virus. Comp Immunol Microbiol Infect Dis 2007 : 30 : 309 327.
40. Fields BS. The molecular ecology of legionellae. Trends Microbiol 1996 : 4 : 286 290.
41. Fields BS, Benson RF, Besser RE. Legionella and Legionnaires' disease: 25 years of investigation. Clin Microbiol Rev 2002 : 15 : 506 526.
42. Fliermans CB, Cherry WB, Orrison LH, Smith SJ, Tison DL, Pope DH. Ecological distribution of Legionella pneumophila. Appl Environ Microbiol 1981 : 41 : 9 16.
43. Fraser DW, Tsai TR, Orenstein W, Parkin WE, Beecham HJ, Sharrar RG, Harris J, Mallison GF, Martin SM, McDade JE, Shepard CC, Brachman PS. Legionnaires' disease: description of an epidemic of pneumonia. N Engl J Med 1977 : 297 : 1189 1197.
44. Furin J. The clinical management of drug-resistant tuberculosis. Curr Opin Pulm Med 2007 : 13 : 212 217.
45. Garau J. Treatment of drug-resistant pneumococcal pneumonia. Lancet Infect Dis 2002 : 2 : 404 415.
46. Gilsdorf JR, Marrs CF, Foxman B. Haemophilus influenzae: genetic variability and natural selection to identify virulence factors. Infect Immun 2004 : 72 : 2457 2461.
47. Glick TH, Gregg MB, Berman B, Mallison G, Rhodes WW Jr., Kassanoff I. Pontiac fever. An epidemic of unknown etiology in a health department: I. Clinical and epidemiologic aspects. Am J Epidemiol 1978 : 107 : 149 160.
48. Griffith F. The significance of pneumococcal types. J Hyg 1928 : 27 : 113 159.
49. Hampson AW, Mackenzie JS. The influenza viruses. Med J Aust 2006 : 185 : S39 S43.
50. Herbert MA, Hayes S, Deadman ME, Tang CM, Hood DW, Moxon ER. Signature Tagged Mutagenesis of Haemophilus influenzae identifies genes required for in vivo survival. Microb Pathog 2002 : 33 : 211 223.
51. Hessen MT. Influenza in the clinic. Annals of Internal Medicine 2007 : 147 : ITC10-1 ITC10-16.
52. Hope WW, Walsh TJ, Denning DW. The invasive and saprophytic syndromes due to Aspergillus spp. Med Mycol 2005 : 43 (Suppl 1 S207 S238.
53. Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005 : 5 : 609 622.
54. Horwitz MA. Interactions between macrophages and Legionella pneumophila. Curr Top Microbiol Immunol 1992 : 181 : 265 282.
55. Judson MA, Stevens DA. Current pharmacotherapy of allergic bronchopulmonary aspergillosis. Expert Opin Pharmacother 2001 : 2 : 1065 1071.
56. Katz SM, Hammel JM. The effect of drying, heat, and pH on the survival of Legionella pneumophila. Ann Clin Lab Sci 1987 : 17 : 150 156.
57. Keitel WA, Atmar RL. Preparing for a possible pandemic: influenza A/H5N1 vaccine development. Curr Opin Pharmacol 2007 : 7 : 484 490.
58. Kim JO, Weiser JN. Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J Infect Dis 1998 : 177 : 368 377.
59. Klich M. Identification of common aspergillus species. Ulrecht, the Netherlands : Centraalbureau voor Schimmelcultures, 2002.
60. Kradin RL, Mark EJ. The pathology of pulmonary disorders due to Aspergillus spp. Arch Pathol Lab Med 2008 : 132 : 606 614.
61. Kubak BM. Fungal infection in lung transplantation. Transpl Infect Dis 2002 : 4 (Suppl 3 24 31.
62. Kyaw MH, Christie P, Clarke SC, Mooney JD, Ahmed S, Jones IG, Campbell H. Invasive pneumococcal disease in Scotland, 1999-2001: use of record linkage to explore associations between patients and disease in relation to future vaccination policy. Clin Infect Dis 2003 : 37 : 1283 1291.
63. Lagrou K, Massonet C, Theunissen K, Meersseman W, Lontie M, Verbeken E, Van Eldere J, Maertens J. Fatal pulmonary infection in a leukaemic patient caused by Hormographiella aspergillata. J Med Microbiol 2005 : 54 : 685 688.
64. Latge JP. The pathobiology of Aspergillus fumigatus. Trends Microbiol 2001 : 9 : 382 389.
65. Lepine LA, Jernigan DB, Butler JC, Pruckler JM, Benson RF, Kim G, Hadler JL, Cartter ML, Fields BS. A recurrent outbreak of nosocomial legionnaires' disease detected by urinary antigen testing: evidence for long-term colonization of a hospital plumbing system. Infect Control Hosp Epidemiol 1998 : 19 : 905 910.
66. Lisby G, Dessau R. Construction of a DNA amplification assay for detection of Legionella species in clinical samples. Eur J Clin Microbiol Infect Dis 1994 : 13 : 225 231.
67. Mahbubani MH, Bej AK, Miller R, Haff L, DiCesare J, Atlas RM. Detection of Legionella with polymerase chain reaction and gene probe methods. Mol Cell Probes 1990 : 4 : 175 187.
68. Marston BJ, Plouffe JF, File TM Jr., Hackman BA, Salstrom SJ, Lipman HB, Kolczak MS, Breiman RF. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med 1997 : 157 : 1709 1718.
69. Maschmeyer G, Haas A, Cornely OA. Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients. Drugs 2007 : 67 : 1567 1601.
70. McChlery SM, Kerrigan J, Clarke SC. Whole gene pneumolysin PCR can be used as a diagnostic assay but cannot predict serotype. Br J Biomed Sci 2004 : 61 : 31 33.
71. McChlery SM, Scott KJ, Clarke SC. Clonal analysis of invasive pneumococcal isolates in Scotland and coverage of serotypes by the licensed conjugate polysaccharide pneumococcal vaccine: possible implications for UK vaccine policy. Eur J Clin Microbiol Infect Dis 2005 : 24 : 262 267.
72. McLintock LA, Gibson BE, Jones BL. Mixed pulmonary fungal infection with Aspergillus fumigatus and Absidia corymbifera in a patient with relapsed acute myeloid leukaemia. Br J Haematol 2005 : 128 : 737.
73. Meats E, Feil EJ, Stringer S, Cody AJ, Goldstein R, Kroll JS, Popovic T, Spratt BG. Characterization of encapsulated and noncapsulated Haemophilus influenzae and determination of phylogenetic relationships by multilocus sequence typing. J Clin Microbiol 2003 : 41 : 1623 1636.
74. Meredith S, Watson JM, Citron KM, Cockcroft A, Darbyshire JH. Are healthcare workers in England and Wales at increased risk of tuberculosis? BMJ 1996 : 313 : 522 525.
75. Mohan PV, Heath PT. Pneumococcal disease in childhood. Hosp Med 2001 : 62 : 406 409.
76. Nuermberger E, Bishai WR. The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative. Clin Infect Dis 2004 : 38 : 99 103.
77. Obaro S, Adegbola R. The pneumococcus: carriage, disease and conjugate vaccines. J Med Microbiol 2002 : 51 : 98 104.
78. Perfect JR, Wong B, Chang YC, Kwon-Chung KJ, Williamson PR. Cryptococcus neoformans: virulence and host defences. Med Mycol 1998 : 36 (Suppl 1 79 86.
79. Pound MW, Drew RH, Perfect JR. Recent advances in the epidemiology, prevention, diagnosis, and treatment of fungal pneumonia. Curr Opin Infect Dis 2002 : 15 : 183 194.
80. Proud D, Reynolds CJ, Lacapra S, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis 1988 : 137 : 613 616.
81. Quezada G, Koshkina NV, Zweidler-McKay P, Zhou Z, Kontoyiannis DP, Kleinerman ES. Intranasal granulocyte-macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis. Antimicrob Agents Chemother 2008 : 52 : 716 718.
82. Raghavendran K, Mylotte JM, Scannapieco FA. Nursing home-associated pneumonia, hospital-acquired pneumonia and ventilator-associated pneumonia: the contribution of dental biofilms and periodontal inflammation. Periodontol 2000 2007 : 44 : 164 177.
83. Rao VK, Krasan GP, Hendrixson DR, Dawid S, St Geme JW III. Molecular determinants of the pathogenesis of disease due to non-typable Haemophilus influenzae. FEMS Microbiol Rev 1999 : 23 : 99 129.
84. Raviglione MC, Smith IM. XDR tuberculosis-implications for global public health. N Engl J Med 2007 : 356 : 656 659.
85. Rennie RP, Ibrahim KH. Antimicrobial resistance in Haemophilus influenzae: how can we prevent the inevitable? Commentary on antimicrobial resistance in H. influenzae based on data from the TARGETed surveillance program. Clin Infect Dis 2005 : 41 (Suppl 4 S234 S238.
86. Roson B, Fernandez-Sabe N, Carratala J, Verdaguer R, Dorca J, Manresa F, Gudiol F. Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia. Clin Infect Dis 2004 : 38 : 222 226.
87. Scott RS, Sutton DA, Jagirdar J. Lung infection due to opportunistic fungus, Phialemonium obovatum, in a bone marrow transplant recipient: an emerging infection with fungemia and Crohn disease-like involvement of the gastrointestinal tract. Ann Diagn Pathol 2005 : 9 : 227 230.
88. Shibuya K, Hirata A, Omuta J, Sugamata M, Katori S, Saito N, Murata N, Morita A, Takahashi K, Hasegawa C, Mitsuda A, Hatori T, Nonaka H. Granuloma and cryptococcosis. J Infect Chemother 2005 : 11 : 115 122.
89. Shigemitsu H, Afshar K. Aspiration pneumonias: under-diagnosed and under-treated. Curr Opin Pulm Med 2007 : 13 : 192 198.
90. Simasek M, Blandino DA. Treatment of the common cold. Am Fam Physician 2007 : 75 : 515 520.
91. Singh N, Limaye AP, Forrest G, Safdar N, Munoz P, Pursell K, Houston S, Rosso F, Montoya JG, Patton P, Del Busto R, Aguado JM, Fisher RA, Klintmalm GB, Miller R, Wagener MM, Lewis RE, Kontoyiannis DP, Husain S. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation 2006 : 81 : 320 326.
92. Slavin RG, Hutcheson PS, Chauhan B, Bellone CJ. An overview of allergic bronchopulmonary aspergillosis with some new insights. Allergy Asthma Proc 2004 : 25 : 395 399.
93. Sleeman K, Knox K, George R, Miller E, Waight P, Griffiths D, Efstratiou A, Broughton K, Mayon-White RT, Moxon ER, Crook DW. Invasive pneumococcal disease in England and Wales: vaccination implications. J Infect Dis 2001 : 183 : 239 246.
94. Smart LE. Serotyping of Streptococcus pneumoniae strains by coagglutination. J Clin Pathol 1986 : 39 : 328 331.
95. Sodqi M, Brazille P, Gonzalez-Canali G, Cornet M, Piketty C, Weiss L. Unusual pulmonary Enterocytozoon bieneusi microsporidiosis in an AIDS patient: case report and review. Scand J Infect Dis 2004 : 36 : 230 231.
96. Steele TW. Legionnaires' disease in South Australia, 1979-1988. Med J Aust 1989 : 151 : 322, 325 326, 328.
97. Stringer JR, Beard CB, Miller RF, Wakefield AE. A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis 2002 : 8 : 891 896.
98. Surmont I, Van Aelst F, Verbanck J, De Hoog GS. A pulmonary infection caused by Coprinus cinereus (Hormographiella aspergillata) diagnosed after a neutropenic episode. Med Mycol 2002 : 40 : 217 219.
99. Swanson MS, Sturgill-Koszycki I. Exploitation of macrophages as a replication niche by Legionella pneumophila. Trends Microbiol 2000 : 8 : 47 49.
100. Szymanska J. Risk of exposure to Legionella in dental practice. Ann Agric Environ Med 2004 : 11 : 9 12.
101. Thomas CF Jr., Limper AH. Pneumocystis pneumonia. N Engl J Med 2004 : 350 : 2487 2498.
102. Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev 2007 : 20 : 368 389.
103. Turk DC. Acute laryngeal obstruction due to haemophilus. Lancet 1967 : 2 : 895.
104. van Ulsen P, van Schilfgaarde M, Dankert J, Jansen H, van Alphen L. Genes of non-typeable Haemophilus influenzae expressed during interaction with human epithelial cell lines. Mol Microbiol 2002 : 45 : 485 500.
105. Vanittanakom N, Supabandhu J, Khamwan C, Praparattanapan J, Thirach S, Prasertwitayakij N, Louthrenoo W, Chiewchanvit S, Tananuvat N. Identification of emerging human-pathogenic Pythium insidiosum by serological and molecular assay-based methods. J Clin Microbiol 2004 : 42 : 3970 3974.
106. Vestbo J. Chronic bronchitis: should it worry us? Chron Respir Dis 2004 : 1 : 173 176.
107. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, van Burik JA, Wingard JR, Patterson TF. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008 : 46 : 327 360.
108. Warris A, Verweij PE. Clinical implications of environmental sources for Aspergillus. Med Mycol 2005 : 43 (Suppl 1 S59 S65.
109. Wenzel RP, Fowler AA III. Clinical practice. Acute bronchitis. N Engl J Med 2006 : 355 : 2125 2130.
110. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003 : 348 : 1737 1746.
111. WHO. Haemophilus influenzae type B (HiB). Geneva, Switzerland : World Health Organisation, 2005, p. 294.
112. Wiker HG, Mustafa T, Malen H, Riise AM. Vaccine approaches to prevent tuberculosis. Scand J Immunol 2006 : 64 : 243 250.
113. Yao Z, Liao W. Fungal respiratory disease. Curr Opin Pulm Med 2006 : 12 : 222 227.
114. Zhou J, Enright MC, Spratt BG. Identification of the major Spanish clones of penicillin-resistant pneumococci via the Internet using multilocus sequence typing. J Clin Microbiol 2000 : 38 : 977 986.
115. Zmeili OS, Soubani AO. Pulmonary aspergillosis: a clinical update. QJM 2007 : 100 : 317 334.